Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,530 | 22 | 57.3% |
| Food and Beverage | $23,115 | 779 | 31.9% |
| Consulting Fee | $5,500 | 2 | 7.6% |
| Travel and Lodging | $2,060 | 5 | 2.8% |
| Education | $253.59 | 17 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $54,832 | 176 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,735 | 155 | $0 (2024) |
| Amgen Inc. | $3,662 | 94 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,249 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,118 | 43 | $0 (2024) |
| Lilly USA, LLC | $1,085 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $822.37 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $729.60 | 30 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $703.89 | 25 | $0 (2024) |
| Amarin Pharma Inc. | $603.14 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,474 | 128 | AstraZeneca Pharmaceuticals LP ($1,276) |
| 2023 | $3,385 | 113 | Gilead Sciences, Inc. ($816.96) |
| 2022 | $2,749 | 113 | Amgen Inc. ($690.16) |
| 2021 | $8,086 | 108 | Gilead Sciences, Inc. ($5,930) |
| 2020 | $3,457 | 51 | Gilead Sciences, Inc. ($2,707) |
| 2019 | $19,965 | 111 | Gilead Sciences, Inc. ($18,259) |
| 2018 | $12,063 | 99 | Gilead Sciences, Inc. ($10,605) |
| 2017 | $17,279 | 102 | Gilead Sciences Inc ($15,833) |
All Payment Transactions
825 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Cardio-renal | ||||||
| 12/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.17 | General |
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.17 | General |
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: GI | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $26.99 | General |
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $140.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 11/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.82 | General |
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $29.95 | General |
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $6.80 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: HBV | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.49 | General |
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 293 | 513 | $75,392 | $31,659 |
| 2022 | 10 | 366 | 674 | $94,806 | $39,991 |
| 2021 | 15 | 796 | 1,270 | $165,032 | $79,083 |
| 2020 | 12 | 727 | 1,296 | $163,430 | $67,628 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 218 | $35,970 | $13,433 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $8,060 | $4,529 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 43 | $10,320 | $3,652 | 35.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 26 | 46 | $7,360 | $3,297 | 44.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 39 | 41 | $6,560 | $2,213 | 33.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,750 | $2,063 | 75.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 29 | 30 | $1,807 | $995.40 | 55.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 26 | $1,560 | $912.34 | 58.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 67 | $1,005 | $562.80 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 268 | $44,220 | $18,154 | 41.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 42 | 94 | $15,040 | $6,318 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $8,580 | $4,981 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 53 | $12,720 | $4,660 | 36.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 35 | 36 | $5,760 | $2,135 | 37.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 32 | 32 | $1,927 | $1,009 | 52.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,224 | $1,004 | 82.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 20 | $2,000 | $800.78 | 40.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 18 | 20 | $2,000 | $665.94 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 50 | 89 | $1,335 | $264.12 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 364 | $58,725 | $28,552 | 48.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 84 | 212 | $33,020 | $14,998 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 62 | 62 | $16,120 | $9,597 | 59.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 88 | $20,200 | $8,242 | 40.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 78 | 91 | $14,560 | $5,332 | 36.6% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 74 | 74 | $5,921 | $3,463 | 58.5% |
About Dr. Eric Zhou, MD
Dr. Eric Zhou, MD is a Nephrology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689674855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Zhou, MD has received a total of $72,458 in payments from pharmaceutical and medical device companies, with $5,474 received in 2024. These payments were reported across 825 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,530).
As a Medicare-enrolled provider, Zhou has provided services to 2,182 Medicare beneficiaries, totaling 3,753 services with total Medicare billing of $218,361. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine
- Location New York, NY
- Active Since 07/28/2005
- Last Updated 07/17/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689674855
Products in Payments
- Vemlidy (Drug) $46,779
- Otezla (Drug) $1,463
- FARXIGA (Drug) $1,391
- JARDIANCE (Drug) $1,077
- BREZTRI (Drug) $813.22
- Prolia (Biological) $696.02
- Repatha (Biological) $621.55
- Vascepa (Drug) $603.14
- XARELTO (Drug) $559.71
- LOKELMA (Drug) $544.60
- JANUVIA (Drug) $525.03
- Kerendia (Drug) $515.85
- TRULICITY (Drug) $461.96
- EVENITY (Biological) $441.80
- AIRSUPRA (Drug) $431.10
- TRELEGY ELLIPTA (Drug) $393.40
- Auvelity (Drug) $378.19
- AREXVY (Drug) $373.55
- Aimovig (Biological) $364.47
- UBRELVY (Drug) $276.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in New York
Dr. Gerald Appel, M.d, M.D
Nephrology — Payments: $842,842
Dr. Richard Chan, Md, MD
Nephrology — Payments: $525,489
Dr. Steven Coca, D.o., M.s, D.O., M.S
Nephrology — Payments: $388,012
Dr. Jai Radhakrishnan, M.d, M.D
Nephrology — Payments: $243,935
Dr. David Bernard, Md, MD
Nephrology — Payments: $235,726
Dr. Girish Nadkarni, Md, MD
Nephrology — Payments: $217,113